{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:13:25Z","timestamp":1789186405683,"version":"build-2803163510"},"reference-count":109,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In 2023, the new European guidelines on severe community-acquired pneumonia, providing clinical practice recommendations for the management of this life-threatening infection, characterized by a high burden of mortality, morbidity, and costs for the society. This review article aims to summarize the principal evidence related to eight different questions covered in the guidelines, by also highlighting the future perspectives for research activity.<\/jats:p>","DOI":"10.1055\/s-0043-1777797","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:16:52Z","timestamp":1709338612000},"page":"274-286","source":"Crossref","is-referenced-by-count":12,"title":["New Guidelines for Severe Community-acquired Pneumonia"],"prefix":"10.1055","volume":"45","author":[{"given":"Davide","family":"Calabretta","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy"},{"name":"Institut d'Investigacions Biom\u00e8diques August Pi I Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Mart\u00ecn-Loeches","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organisation (MICRO), St James's Hospital, Dublin, Ireland"},{"name":"Trinity College Dublin, Dublin, Ireland"},{"name":"CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain"},{"name":"Department of Pulmonology, Hospital Cl\u00ednic of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[{"name":"Institut d'Investigacions Biom\u00e8diques August Pi I Sunyer (IDIBAPS), Barcelona, Spain"},{"name":"Department of Medicine, University of Barcelona, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41572-021-00259-0","article-title":"Pneumonia","volume":"7","author":"A Torres","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/QCO.0000000000000819","article-title":"Choosing antibiotic therapy for severe community-acquired pneumonia","volume":"35","author":"I Martin-Loeches","year":"2022","journal-title":"Curr Opin Infect Dis"},{"issue":"06","key":"ref3","doi-asserted-by":"crossref","first-page":"567.e1","DOI":"10.1016\/j.cmi.2016.03.015","article-title":"Declining mortality among hospitalized patients with community-acquired pneumonia","volume":"22","author":"A F Simonetti","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/thoraxjnl-2014-206744","article-title":"Community-acquired pneumonia as medical emergency: predictors of early deterioration","volume":"70","author":"M Kolditz","year":"2015","journal-title":"Thorax"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.chest.2020.03.051","article-title":"The burden of community-acquired pneumonia requiring admission to ICU in the United States","volume":"158","author":"R Cavallazzi","year":"2020","journal-title":"Chest"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"e0191721","DOI":"10.1371\/journal.pone.0191721","article-title":"Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients","volume":"13","author":"M Ferrer","year":"2018","journal-title":"PLoS ONE"},{"issue":"05","key":"ref7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/bjaed\/mkv052","article-title":"Severe community-acquired pneumonia","volume":"16","author":"A J Morgan","year":"2016","journal-title":"BJA Educ"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41479-020-00074-3","article-title":"Etiology of community-acquired pneumonia in adults: a systematic review","volume":"12","author":"S Shoar","year":"2020","journal-title":"Pneumonia"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00134-020-06323-9","article-title":"Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study","volume":"47","author":"A Rouz\u00e9","year":"2021","journal-title":"Intensive Care Med"},{"key":"ref10","first-page":"1","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia","author":"I Martin-Loeches","year":"2023","journal-title":"Intensive Care Med"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1055\/s-0041-1739359","article-title":"Classical and molecular techniques to diagnose HAP\/VAP","volume":"43","author":"C Renaud","year":"2022","journal-title":"Semin Respir Crit Care Med"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/QCO.0000000000000254","article-title":"Empiric antibiotic selection and risk prediction of drug-resistant pathogens in community-onset pneumonia","volume":"29","author":"B J Webb","year":"2016","journal-title":"Curr Opin Infect Dis"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/thoraxjnl-2021-216990","article-title":"Multicentre evaluation of two multiplex PCR platforms for the rapid microbiological investigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study","volume":"77","author":"V I Enne","year":"2022","journal-title":"Thorax"},{"issue":"166","key":"ref14","doi-asserted-by":"crossref","first-page":"220123","DOI":"10.1183\/16000617.0123-2022","article-title":"Severe community-acquired pneumonia","volume":"31","author":"M S Niederman","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"05","key":"ref15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.chest.2019.04.093","article-title":"Antibiotic use and outcomes after implementation of the drug resistance in pneumonia score in ED patients with community-onset pneumonia","volume":"156","author":"B J Webb","year":"2019","journal-title":"Chest"},{"issue":"04","key":"ref16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamainternmed.2019.7495","article-title":"Empirical anti-MRSA vs standard antibiotic therapy and risk of 30-day mortality in patients hospitalized for pneumonia","volume":"180","author":"B E Jones","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"07","key":"ref17","doi-asserted-by":"crossref","first-page":"e00128","DOI":"10.1128\/JCM.00128-20","article-title":"Multicenter evaluation of the BioFire FilmArray Pneumonia\/Pneumonia Plus Panel for detection and quantification of agents of lower respiratory tract infection","volume":"58","author":"C N Murphy","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"03","key":"ref18","doi-asserted-by":"crossref","first-page":"e02497","DOI":"10.1128\/JCM.02497-20","article-title":"Multicenter evaluation of the Unyvero Platform for testing bronchoalveolar lavage fluid","volume":"59","author":"M Klein","year":"2021","journal-title":"J Clin Microbiol"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"115179","DOI":"10.1016\/j.diagmicrobio.2020.115179","article-title":"A multiplex polymerase chain reaction assay for antibiotic stewardship in suspected pneumonia","volume":"98","author":"C Pickens","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"05","key":"ref20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S2213-2600(17)30120-0","article-title":"Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial","volume":"5","author":"N J Brendish","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"07","key":"ref21","doi-asserted-by":"crossref","first-page":"e00135","DOI":"10.1128\/JCM.00135-20","article-title":"Practical comparison of the BioFire FilmArray Pneumonia Panel to routine diagnostic methods and potential impact on antimicrobial stewardship in adult hospitalized patients with lower respiratory tract infections","volume":"58","author":"B W Buchan","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"07","key":"ref22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41587-019-0156-5","article-title":"Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection","volume":"37","author":"T Charalampous","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"06","key":"ref23","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1183\/13993003.01144-2016","article-title":"Laboratory diagnosis of pneumonia in the molecular age","volume":"48","author":"A Torres","year":"2016","journal-title":"Eur Respir J"},{"issue":"07","key":"ref24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/14787210.2019.1635010","article-title":"Emerging strategies for the noninvasive diagnosis of nosocomial pneumonia","volume":"17","author":"A Liapikou","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref25","first-page":"w13095","article-title":"Comparison of MALDI TOF with conventional identification of clinically relevant bacteria","volume":"140","author":"M Risch","year":"2010","journal-title":"Swiss Med Wkly"},{"issue":"07","key":"ref26","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.cmi.2017.10.016","article-title":"Rapid detection of antibiotic resistance by MALDI-TOF mass spectrometry using a novel direct-on-target microdroplet growth assay","volume":"24","author":"E A Idelevich","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"05","key":"ref27","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/v13050730","article-title":"Superiority of MALDI-TOF mass spectrometry over real-time PCR for SARS-CoV-2 RNA detection","volume":"13","author":"M Rybicka","year":"2021","journal-title":"Viruses"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41479-017-0028-z","article-title":"Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study","volume":"9","author":"L M Mayer","year":"2017","journal-title":"Pneumonia"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jclinepi.2016.07.006","article-title":"Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group","volume":"80","author":"G H Guyatt","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"09","key":"ref30","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/cid\/civ629","article-title":"Trends in antibiotic use and nosocomial pathogens in hospitalized veterans with pneumonia at 128 medical centers, 2006-2010","volume":"61","author":"B E Jones","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"08","key":"ref31","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1017\/ice.2017.98","article-title":"Variation in empiric coverage versus detection of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in hospitalizations for community-onset pneumonia across 128 US Veterans Affairs Medical Centers","volume":"38","author":"B E Jones","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S1473-3099(16)30267-5","article-title":"Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study","volume":"16","author":"S Aliberti","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"02","key":"ref33","doi-asserted-by":"crossref","first-page":"1701190","DOI":"10.1183\/13993003.01190-2017","article-title":"Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients","volume":"52","author":"M I Restrepo","year":"2018","journal-title":"Eur Respir J"},{"issue":"05","key":"ref34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/resp.13663","article-title":"Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia","volume":"25","author":"D Villafuerte","year":"2020","journal-title":"Respirology"},{"issue":"05","key":"ref35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. Adults","volume":"373","author":"S Jain","year":"2015","journal-title":"N Engl J Med"},{"issue":"03","key":"ref36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/MCP.0000000000000670","article-title":"Strategies for prediction of drug-resistant pathogens and empiric antibiotic selection in community-acquired pneumonia","volume":"26","author":"R Gil","year":"2020","journal-title":"Curr Opin Pulm Med"},{"issue":"02","key":"ref37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1513\/AnnalsATS.201407-305OC","article-title":"Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia","volume":"12","author":"E Prina","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"08","key":"ref38","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/rccm.201301-0079OC","article-title":"Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia","volume":"188","author":"Y Shindo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"01","key":"ref39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1471-2334-13-268","article-title":"A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia","volume":"13","author":"A F Shorr","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"04","key":"ref40","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cir840","article-title":"Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia","volume":"54","author":"S Aliberti","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"04","key":"ref41","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccm.2007.08.004","article-title":"Pneumonia in the older patient","volume":"28","author":"M S Niederman","year":"2007","journal-title":"Clin Chest Med"},{"issue":"06","key":"ref42","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1378\/chest.09-2434","article-title":"Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia?","volume":"137","author":"M P Schreiber","year":"2010","journal-title":"Chest"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1128\/AAC.03071-15","article-title":"Derivation and multicenter validation of the drug resistance in Pneumonia Clinical Prediction Score","volume":"60","author":"B J Webb","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"07","key":"ref44","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/ciy631","article-title":"A therapeutic strategy for all pneumonia patients: a 3-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy","volume":"68","author":"T Maruyama","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"09","key":"ref45","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1513\/AnnalsATS.201906-459OC","article-title":"Definitive and indeterminate Pseudomonas aeruginosa infection in adults with community-acquired pneumonia: a prospective observational study","volume":"18","author":"E Sando","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"09","key":"ref46","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1513\/AnnalsATS.202107-762ED","article-title":"Too much or too little empiric treatment for Pseudomonas aeruginosa in community-acquired pneumonia?","volume":"18","author":"A Torres","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"02","key":"ref47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.arbres.2022.09.005","article-title":"Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia","volume":"59","author":"S Pascual-Guardia","year":"2023","journal-title":"Archivos de Bronconeumologia"},{"issue":"03","key":"ref48","doi-asserted-by":"crossref","first-page":"ofaa065","DOI":"10.1093\/ofid\/ofaa065","article-title":"Antibiotic treatment failure and associated outcomes among adult patients with community-acquired pneumonia in the outpatient setting: a real-world US Insurance Claims Database Study","volume":"7","author":"G Tillotson","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"05","key":"ref49","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/17476348.2.5.565","article-title":"Biomarkers in the management of pneumonia","volume":"2","author":"M Christ-Crain","year":"2008","journal-title":"Expert Rev Respir Med"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/cc8155","article-title":"Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia","volume":"14","author":"M Christ-Crain","year":"2010","journal-title":"Crit Care"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"375","author":"L Bouadma","year":"2010","journal-title":"Lancet"},{"issue":"01","key":"ref52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"P Schuetz","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"08","key":"ref53","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s00134-023-07161-1","article-title":"Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients","volume":"49","author":"F Galli","year":"2023","journal-title":"Intensive Care Medicine"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1542\/peds.2014-1946","article-title":"Diagnosis of viral infections using myxovirus resistance protein A (MxA)","volume":"135","author":"I Engelmann","year":"2015","journal-title":"Pediatrics"},{"issue":"01","key":"ref55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13052-020-0770-3","article-title":"Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review","volume":"46","author":"J Thomas","year":"2020","journal-title":"Ital J Pediatr"},{"issue":"09","key":"ref56","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1164\/rccm.201605-0916OC","article-title":"Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure","volume":"195","author":"T Mauri","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"16","key":"ref57","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2015.12402","article-title":"Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial","volume":"314","author":"V Lemiale","year":"2015","journal-title":"JAMA"},{"issue":"23","key":"ref58","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure","volume":"372","author":"J P Frat","year":"2015","journal-title":"N Engl J Med"},{"issue":"07","key":"ref59","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00134-014-3325-5","article-title":"Helmet CPAP vs. oxygen therapy in severe hypoxemic respiratory failure due to pneumonia","volume":"40","author":"A M Brambilla","year":"2014","journal-title":"Intensive Care Med"},{"issue":"01","key":"ref60","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1378\/chest.09-2290","article-title":"Helmet continuous positive airway pressure vs oxygen therapy to improve oxygenation in community-acquired pneumonia: a randomized, controlled trial","volume":"138","author":"R Cosentini","year":"2010","journal-title":"Chest"},{"issue":"07","key":"ref61","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200102153440703","article-title":"Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure","volume":"344","author":"G Hilbert","year":"2001","journal-title":"N Engl J Med"},{"issue":"05","key":"ref62","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1164\/ajrccm.160.5.9903015","article-title":"Acute respiratory failure in patients with severe community-acquired pneumonia","volume":"160","author":"M Confalonieri","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"ref63","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1001\/jama.2016.6338","article-title":"Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: a randomized clinical trial","volume":"315","author":"B K Patel","year":"2016","journal-title":"JAMA"},{"issue":"03","key":"ref64","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1164\/rccm.201904-0841OC","article-title":"Physiological comparison of high-flow nasal cannula and helmet noninvasive ventilation in acute hypoxemic respiratory failure","volume":"201","author":"D L Grieco","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"09","key":"ref65","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2044.2008.05536.x","article-title":"Performance of oxygen delivery devices when the breathing pattern of respiratory failure is simulated","volume":"63","author":"M AB Sim","year":"2008","journal-title":"Anaesthesia"},{"issue":"11","key":"ref66","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s00134-011-2354-6","article-title":"Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study","volume":"37","author":"B Sztrymf","year":"2011","journal-title":"Intensive Care Med"},{"issue":"03","key":"ref67","doi-asserted-by":"crossref","first-page":"2201426","DOI":"10.1183\/13993003.01426-2022","article-title":"Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis","volume":"61","author":"J Riera","year":"2023","journal-title":"Eur Respir J"},{"issue":"07","key":"ref68","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00134-023-07050-7","article-title":"ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies","volume":"49","author":"G Grasselli","year":"2023","journal-title":"Intensive Care Med"},{"issue":"04","key":"ref69","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/rccm.200311-1578OC","article-title":"Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia","volume":"170","author":"L M Baddour","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"02","key":"ref70","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1378\/chest.128.2.940","article-title":"The controversy of combination vs monotherapy in the treatment of hospitalized community-acquired pneumonia","volume":"128","author":"K Weiss","year":"2005","journal-title":"Chest"},{"issue":"01","key":"ref71","first-page":"CD011825","article-title":"Adverse events in people taking macrolide antibiotics versus placebo for any indication","volume":"1","author":"M P Hansen","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"ref72","first-page":"253S","article-title":"Fluoroquinolone adverse effects and drug interactions","volume":"21","author":"D N Fish","year":"2001","journal-title":"Pharmacotherapy"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000320319","article-title":"Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms","volume":"81","author":"J Altenburg","year":"2011","journal-title":"Respiration"},{"issue":"04","key":"ref74","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00134-009-1730-y","article-title":"Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia","volume":"36","author":"I Martin-Loeches","year":"2010","journal-title":"Intensive Care Med"},{"issue":"10","key":"ref75","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1164\/rccm.200603-350OC","article-title":"A worldwide perspective of atypical pathogens in community-acquired pneumonia","volume":"175","author":"F W Arnold","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"01","key":"ref76","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/cc3934","article-title":"The impact of empiric antimicrobial therapy with a \u03b2-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia","volume":"10","author":"E M Mortensen","year":"2005","journal-title":"Crit Care"},{"issue":"08","key":"ref77","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1097\/CCM.0b013e31825151a8","article-title":"Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia","volume":"40","author":"B Z Wilson","year":"2012","journal-title":"Crit Care Med"},{"issue":"02","key":"ref78","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/CCM.0b013e3182a66b9b","article-title":"Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis","volume":"42","author":"W I Sligl","year":"2014","journal-title":"Crit Care Med"},{"issue":"06","key":"ref79","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1186\/cc13095","article-title":"Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance","volume":"17","author":"C Adrie","year":"2013","journal-title":"Crit Care"},{"issue":"06","key":"ref80","doi-asserted-by":"crossref","first-page":"e0178022","DOI":"10.1371\/journal.pone.0178022","article-title":"Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: a post-hoc exploratory analysis of a randomized controlled trial","volume":"12","author":"A Ceccato","year":"2017","journal-title":"PLoS ONE"},{"issue":"10","key":"ref81","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cmi.2017.06.010","article-title":"New and improved? A review of novel antibiotics for Gram-positive bacteria","volume":"23","author":"M Abbas","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"04","key":"ref82","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/14728214.2019.1685494","article-title":"Emerging antibiotics for community-acquired pneumonia","volume":"24","author":"A Liapikou","year":"2019","journal-title":"Expert Opin Emerg Drugs"},{"issue":"01","key":"ref83","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40121-020-00378-3","article-title":"Treatment of community-acquired pneumonia: a focus on lefamulin","volume":"10","author":"N Eraikhuemen","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"12","key":"ref84","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3390\/antibiotics9120905","article-title":"Use of oral tetracyclines in the treatment of adult patients with community-acquired bacterial pneumonia: a literature review on the often-overlooked antibiotic class","volume":"9","author":"M R Bidell","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"02","key":"ref85","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/antibiotics10020170","article-title":"Ceftobiprole perspective: current and potential future indications","volume":"10","author":"T Lupia","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"04","key":"ref86","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0040-1709992","article-title":"Staphylococcus aureus pneumonia in the community","volume":"41","author":"H He","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"02","key":"ref87","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00134-019-05519-y","article-title":"Challenges in severe community-acquired pneumonia: a point-of-view review","volume":"45","author":"A Torres","year":"2019","journal-title":"Intensive Care Med"},{"issue":"12","key":"ref88","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1080\/14787210.2022.2134116","article-title":"Updates in the management of respiratory virus infections in ICU patients: revisiting the non-SARS-CoV-2 pathogens","volume":"20","author":"O Saura","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"05","key":"ref89","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/ciy163","article-title":"A randomized study evaluating the effectiveness of oseltamivir initiated at the time of hospital admission in adults hospitalized with influenza-associated lower respiratory tract infections","volume":"67","author":"J Ramirez","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref90","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S2213-2600(16)30435-0","article-title":"Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial","volume":"5","author":"F M Marty","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"21","key":"ref91","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia","volume":"388","author":"P F Dequin","year":"2023","journal-title":"N Engl J Med"},{"issue":"08","key":"ref92","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","article-title":"Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia","volume":"48","author":"G U Meduri","year":"2022","journal-title":"Intensive Care Med"},{"issue":"07","key":"ref93","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial","volume":"313","author":"A Torres","year":"2015","journal-title":"JAMA"},{"issue":"02","key":"ref94","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1378\/chest.104.2.389","article-title":"Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study","volume":"104","author":"P Marik","year":"1993","journal-title":"Chest"},{"issue":"03","key":"ref95","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","article-title":"Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study","volume":"171","author":"M Confalonieri","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"55","key":"ref96","first-page":"91","article-title":"Effects of low-dose hydrocortisone in ICU patients with severe community-acquired pneumonia","volume":"2006","author":"A El-Ghamrawy","year":"2006","journal-title":"Egypt J Chest Dis Tuberc"},{"issue":"02","key":"ref97","first-page":"73","article-title":"Corticosteroids and ICU course of community acquired pneumonia in Egyptian settings","volume":"2","author":"N A Sabry","year":"2011","journal-title":"Pharmacy (Basel)"},{"issue":"02","key":"ref98","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1532-5415.2005.00608.x","article-title":"Differences in the features of aspiration pneumonia according to site of acquisition: community or continuing care facility","volume":"54","author":"M Reza Shariatzadeh","year":"2006","journal-title":"J Am Geriatr Soc"},{"issue":"07","key":"ref99","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1056\/NEJMra1714562","article-title":"Aspiration pneumonia","volume":"380","author":"L A Mandell","year":"2019","journal-title":"N Engl J Med"},{"issue":"07","key":"ref100","doi-asserted-by":"crossref","first-page":"e0254261","DOI":"10.1371\/journal.pone.0254261","article-title":"Characteristics of aspiration pneumonia patients in acute care hospitals: a multicenter, retrospective survey in Northern Japan","volume":"16","author":"J Suzuki","year":"2021","journal-title":"PLoS One"},{"issue":"06","key":"ref101","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00455-022-10412-w","article-title":"Mortality from aspiration pneumonia: incidence, trends, and risk factors","volume":"37","author":"T Gupte","year":"2022","journal-title":"Dysphagia"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2147\/CIA.S183344","article-title":"Antibacterial treatment of aspiration pneumonia in older people: a systematic review","volume":"13","author":"T J Bowerman","year":"2018","journal-title":"Clin Interv Aging"},{"issue":"04","key":"ref103","first-page":"1276","article-title":"Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients","volume":"127","author":"M Kadowaki","year":"2005","journal-title":"Chest"},{"issue":"01","key":"ref104","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1186\/s12879-014-0685-y","article-title":"Effectiveness of azithromycin in aspiration pneumonia: a prospective observational study","volume":"14","author":"S Marumo","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"07","key":"ref105","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3760\/cma.j.issn.0366-6999.20131635","article-title":"Clinical efficacy and safety of moxifloxacin versus levofloxacin plus metronidazole for community-acquired pneumonia with aspiration factors","volume":"127","author":"T Sun","year":"2014","journal-title":"Chin Med J (Engl)"},{"issue":"15","key":"ref106","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2217\/cer-2019-0041","article-title":"Ceftriaxone versus ampicillin\/sulbactam for the treatment of aspiration-associated pneumonia in adults","volume":"8","author":"S Hasegawa","year":"2019","journal-title":"J Comp Eff Res"},{"issue":"02","key":"ref107","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jiac.2019.08.005","article-title":"Cefepime vs. meropenem for moderate-to-severe pneumonia in patients at risk for aspiration: an open-label, randomized study","volume":"26","author":"I Oi","year":"2020","journal-title":"J Infect Chemother"},{"issue":"05","key":"ref108","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.3390\/jcm12051992","article-title":"The clinical significance of anaerobic coverage in the antibiotic treatment of aspiration pneumonia: a systematic review and meta-analysis","volume":"12","author":"Y Yoshimatsu","year":"2023","journal-title":"J Clin Med"},{"issue":"01","key":"ref109","doi-asserted-by":"crossref","first-page":"115821","DOI":"10.1016\/j.diagmicrobio.2022.115821","article-title":"Utilizing procalcitonin in a clinical setting to help differentiate between aspiration pneumonia and aspiration pneumonitis","volume":"105","author":"J Binz","year":"2023","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1777797.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T10:58:20Z","timestamp":1730804300000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1777797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":109,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2024,4,11]]},"published-print":{"date-parts":[[2024,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1777797","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}